Global Contraceptives Market to 2029 – Featuring Reckitt Benckiser, Pfizer and Mayer Laboratories Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Contraceptives Market Analysis by Product (Topical, Oral Contraceptive Pills, Injectable Contraceptives), by Device (Male Condoms, Diaphragms, Female Condoms, Vaginal Rings, Sub Dermal Implants, Intra-Uterine Devices), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global contraceptives market size is estimated to be USD 23.52 billion in 2021 … [Read more…]

Johnson & Johnson’s Executive Vice President, General Counsel Michael Ullmann to Retire; Elizabeth Forminard Named General Counsel, Effective October 17, 2022

NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) today announced that Michael (Mike) Ullmann will retire from his position as Executive Vice President, General Counsel at the end of this year, following 33 years of leadership and service to the Company. Throughout his distinguished career, Mr. Ullmann has worked with the organization’s Board of Directors … [Read more…]

Peoplecare Chooses Boomi and Atturra To Connect Member Data For Personalized Health Fund Experiences

Australian health insurer boosts personalization, improves member value, and supports business compliance with connected data framework CHESTERBROOK, Pa.–(BUSINESS WIRE)–Boomi™, the intelligent connectivity and automation leader, today announced that Peoplecare, an Australian health insurance mutual fund, implemented The Boomi AtomSphere™ Platform to deliver improved member experiences and personalized health insurance with connected, accurate, and accessible data. … [Read more…]

Wysa Secures $20m to Address Global Mental Health Demand With AI Digital Therapeutics

Follows FDA Breakthrough Device Designation and clinical evidence of a Therapeutic Alliance HealthQuad and British International Investment (BII) join earlier investors W Health Ventures, Kae Capital, pi Ventures and Google Assistant Investments Funds will enable access to clinically evidenced digital therapeutics (DTx) in the US, UK, India and other global markets Will enable further reach … [Read more…]

Amylyx Pharmaceuticals Announces Partnership Agreement with Sunnybrook Research Institute to Identify Novel Drug Candidates for Neurodegenerative Diseases

Project to support identification of Bax and Bak inhibitor therapeutic candidates with the potential to treat ALS and other neurodegenerative diseases CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced a two-year sponsored research agreement with Sunnybrook Research Institute (SRI) to expedite the identification of novel drug candidates that inhibit Bax … [Read more…]

HNI Healthcare’s VitalsMD® Software Achieves HITRUST Risk-based, 2-year Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements

HITRUST Risk-based, 2-year Certification validates HNI Healthcare is committed to meeting key regulations and protecting sensitive information AUSTIN, Texas–(BUSINESS WIRE)–HNI Healthcare (HNI), a technology-enabled and data-driven physician practice management company, announces that their VitalsMD® proprietary software has earned certified status for information security by HITRUST. HITRUST Risk-based, 2-year (r2) Certified status demonstrates that the organization’s … [Read more…]

Exactech Launches Significant Update to Equinoxe® Shoulder Preoperative Planning App

Smart technology features humeral planning and other major enhancements that offer surgeons a complete view of patient solutions GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, today announces the U.S. release of the Equinoxe® Shoulder Planning App v2.1, giving surgeons increased flexibility to plan shoulder … [Read more…]

Grail and National Health Service (NHS) England Complete Enrollment of 140,000 Participants in Largest Study of Multi-Cancer Early Detection Test

NHS-Galleri Trial is Evaluating Clinical Utility of GRAIL’s Galleri®, a Multi-Cancer Early Detection Test, Alongside Current Standard of Care in England NHS-Galleri Trial Prioritized Equitable Recruitment Approaches Designed to Achieve Representation of People from Minority Ethnic Backgrounds MENLO PARK, Calif.–(BUSINESS WIRE)–GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can … [Read more…]

Alchemy Wellness Resorts to Partner with Premier Brands to Bring Curated Wellness Services to Guests Worldwide

Launch of Pioneering Hospitality and Wellness Management Company, Led by Industry Veterans Patrick Fernandes and Tammy Pahel MIAMI BEACH, Fla.–(BUSINESS WIRE)–Alchemy Wellness Resorts (“Alchemy” or the “Company”) today announced its launch as a pioneering hospitality and wellness management company dedicated to partnering with resorts and brands to bring curated wellness services to more guests worldwide. … [Read more…]

Radialis PET Imager Receives FDA Clearance

Bringing Medical Insight into Focus THUNDER BAY, Ontario–(BUSINESS WIRE)–Radialis Inc. announces it has received FDA clearance to market the Radialis PET Imager, an advanced organ-targeted positron emission tomography (PET) system, in the United States. The heightened sensitivity of the Radialis PET Imager to radiotracer enables the system to produce functional images with high spatial resolution, … [Read more…]